The CHK1 Inhibitor Prexasertib in BRCA Wild-Type Platinum-Resistant Recurrent High-Grade Serous Ovarian Carcinoma: a Phase 2 Trial

dbGaP FAQdbGaP Access Request Video Tutorial

Platforms

dbGaP

View in dbGaP

phs003588.v1.p1

APIs

Consent Codes

Unspecified

Focus / Diseases

Ovarian Neoplasms

Study Design

Clinical Trial

Data Types

WXS

Subjects

18